Symptom burden: A forgotten area of measurement in inflammatory bowel disease

被引:14
|
作者
Farrell, Dawn [1 ]
Savage, Eileen [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Catherine McAuley Sch Nursing & Midwifery, Cork, Ireland
关键词
Crohn's disease; inflammatory bowel disease; symptom assessment; symptoms; ulcerative colitis; QUALITY-OF-LIFE; EFFICACY END-POINTS; ULCERATIVE-COLITIS; ACTIVITY INDEXES; MEDICAL THERAPY; CLINICAL-TRIALS; ADULTS; PREVALENCE; CANCER; CROHNS;
D O I
10.1111/j.1440-172X.2012.02063.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Inflammatory bowel disease (IBD) collectively known as Crohn's disease and ulcerative colitis are chronic inflammatory diseases of the digestive tract. Periods of active and inactive disease are common along the trajectory of this illness. A range of symptoms such as fatigue, diarrhoea and abdominal pain are experienced and are often very debilitating in nature resulting in significance interference in daily life. Despite this, to date, research in the area of symptoms remains an underexplored topic. This paper aims to discuss current approaches to symptom assessment in IBD and the potential to measure symptom burden in further research, in order to gain a greater understanding into the experiences of individuals with IBD.
引用
收藏
页码:497 / 500
页数:4
相关论文
共 50 条
  • [1] Symptom burden in inflammatory bowel disease: Rethinking conceptual and theoretical underpinnings
    Farrell, Dawn
    Savage, Eileen
    INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2010, 16 (05) : 437 - 442
  • [2] Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease
    Farrell, Dawn
    McCarthy, Geraldine
    Savage, Eileen
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (03) : 315 - 322
  • [3] Symptom clusters in adults with inflammatory bowel disease
    Conley, Samantha
    Proctor, Deborah D.
    Jeon, Sangchoon
    Sandler, Robert S.
    Redeker, Nancy S.
    RESEARCH IN NURSING & HEALTH, 2017, 40 (05) : 424 - 434
  • [4] Symptom management in inflammatory bowel disease
    Abraham, Bincy P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (07) : 953 - 967
  • [5] The Burden of Comedication Among Patients with Inflammatory Bowel Disease
    Buckley, Jessie P.
    Kappelman, Michael D.
    Allen, Jeffery K.
    Van Meter, Susan A.
    Cook, Suzanne F.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (13) : 2725 - 2736
  • [6] The burden of inflammatory bowel disease in Europe
    Burisch, Johan
    Jess, Tine
    Martinato, Matteo
    Lakatos, Peter L.
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) : 322 - 337
  • [7] The Burden of Inflammatory Bowel Disease in Europe in 2020
    Zhao, Mirabella
    Gonczi, Lorant
    Lakatos, Peter L.
    Burisch, Johan
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (09) : 1573 - 1587
  • [8] Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
    D'Haens, Geert
    Ferrante, Marc
    Vermeire, Severine
    Baert, Filip
    Noman, Maja
    Moortgat, Liesbeth
    Geens, Patricia
    Iwens, Doreen
    Aerden, Isolde
    Van Assche, Gert
    Van Olmen, Gust
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2218 - 2224
  • [9] Opioid Use in Patients With Inflammatory Bowel Disease
    Lin, Xiwu
    Lofland, Jennifer
    Zhang, Ling
    Sloan, Sheldon
    Chamaa, Laila
    Marano, Colleen
    Plevy, Scott
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [10] Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease
    Swanson, Garth R.
    Sedghi, Shahriar
    Farhadi, Ashkan
    Keshavarzian, Ali
    ALCOHOL, 2010, 44 (03) : 223 - 228